Twist Bioscience Corporation
NASDAQ:TWST
26.25 (USD) • At close September 8, 2025
 Overzicht | Financiële gegevens
 | Bedrijfsnaam | Twist Bioscience Corporation | 
| Symbool | TWST | 
| Munteenheid | USD | 
| Prijs | 26.25 | 
| Beurswaarde    |  1,584,473,625 | 
| Dividendpercentage    |  0% | 
| 52-weken bereik | 24.28 - 55.33 | 
| Industrie | Diagnostics & Research | 
| Sector | Healthcare | 
| CEO | Dr. Emily Marine Leproust Ph.D. | 
| Website | https://www.twistbioscience.com | 
An error occurred while fetching data.
Over Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, 
 Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)







